Fresh Tracks Therapeutics press release (NASDAQ:FRTX): Q3 GAAP EPS of $0.32. Revenue was $7.9 million for the third quarter of 2023, compared to $0.5 million for the third quarter of 2022.The Company ...
Source LinkFresh Tracks Therapeutics press release (NASDAQ:FRTX): Q3 GAAP EPS of $0.32. Revenue was $7.9 million for the third quarter of 2023, compared to $0.5 million for the third quarter of 2022.The Company ...
Source Link
Comments